StockData
Vaxart, Inc. logo

Vaxart, Inc. (VXRT) stock

VXRTOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/30
$0.48+0.02 (+5.04%)

Close on Oct 19, 2026Market cap $115.15MP/E 3.2Yield –

Vaxart total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Vaxart's total debt was $1.94M at Dec 31, 2018. For fiscal 2018 it was $1.94M, up 548.0% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2018Dec 31, 2018$1.94M+548.0%
FY2016Jun 30, 2016$300.00K-62.5%
FY2015Jun 30, 2015$800.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2018CQ4 2018Dec 31, 2018$1.94M+548.0%
Q3 FY2018CQ3 2018Sep 30, 2018$2.32M+364.2%
Q2 FY2018CQ2 2018Jun 30, 2018$2.70M+285.1%
Q4 FY2016CQ2 2016Jun 30, 2016$300.00K-62.5%
Q3 FY2016CQ1 2016Mar 31, 2016$300.00K–
Q2 FY2016CQ4 2015Dec 31, 2015$500.00K–
Q1 FY2016CQ3 2015Sep 30, 2015$700.00K–
Q4 FY2015CQ2 2015Jun 30, 2015$800.00K–

More Vaxart figures

See a number that looks wrong?